Catastrophic claims could challenge drug plan sustainability
Over the last few years, an increasing number of new medications have been introduced to treat a range of complex diseases. While many of these treatments have proven effective, they also come at high costs—costs that private supplementary health insurance plans are struggling to cover. A recent example is the newly marketed drug Soliris, which […]
- July 15, 2011 September 13, 2019
- 07:00